Histologic evaluation of the tissue seal and biologic response around cochlear implant electrodes in the human

Otology and Neurotology

Volumn 25, Issue 3, 2004, Pages 257-262

  Nadol Jr , Joseph B ^a   Eddington, Donald K ^b  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GELFOAM; TISSUE ADHESIVE;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; COCHLEA PROSTHESIS; COCHLEOSTOMY; ELECTRODE; FEMALE; FUNCTIONAL ANATOMY; GIANT CELL; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; INFLAMMATION; INNER EAR; MALE; MENINGITIS; MIDDLE EAR; MIDDLE EAR RECONSTRUCTION; MONONUCLEAR CELL; POSTOPERATIVE INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSTHESIS INFECTION; TISSUE GRAFT;

AGED; AGED, 80 AND OVER; CHILD; COCHLEAR IMPLANTATION; COCHLEAR IMPLANTS; ELECTRODES, IMPLANTED; FEMALE; HUMANS; INFLAMMATION; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED; OTITIS MEDIA, SUPPURATIVE; POSTOPERATIVE COMPLICATIONS; STAPES SURGERY; TEMPORAL BONE;

EID: 4043162895     PISSN: 15317129     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129492-200405000-00010     Document Type: Article

References (51)

1. Cohen NL, Hoffman RA, Stroschein M. Medical or surgical complications related to the Nucleus multichannel cochlear implant. Ann Otol Rhinol Laryngol Suppl 1988;135:8-13.
2. Hoffman RA, Cohen NL. Complications of cochlear implant surgery. Ann Otol Rhinol Laryngol Suppl 1995;166:420-2.
3. Page EL, Eby TL. Meningitis after cochlear implantation in Mondini malformation. Otolaryngol Head Neck Surg 1997;116:104-6.
4. Daspit CP. Meningitis as a result of a cochlear implant: case report. Otolaryngol Head Neck Surg 1991;105:115-6.
5. Presented at the Meeting on Post Cochlear Implantation Meningitis, Schiphol Airport, Amsterdam, July 5, 2002. Available at: http://www.ukl.uni- freiburg.de/hno/icf/pdf/meningitis-eng.pdf.
6. US Food and Drug Administration Public Health Web Notification: Cochlear implant recipients may be at greater risk for meningitis. Reprinted with the permission from the US FDA Center for Devices and Radiological Health. Originally issued July 24, 2002, Updated: October 17, 2002. Available at: http://www.tsbvi.edu/Outreach/seehear/winter03/fda.htm.
7. Rutledge LJ, Lewis ML, Sanabria F. Fatal meningitis related to stapes operation. Report of a case with temporal bone study. Arch Otolaryngol 1963;78:637-41.
8. Wolff D. Untoward sequelae eleven months following stapedectomy. Ann Otol Rhinol Laryngol 1964;73:297-304.
9. Matz GJ, Lockhart HB, Lindsay JR. Meningitis following stapedectomy. Laryngoscope 1968;78:56-63.
10. Palva T, Palva A, Kärjä AJ. Fatal meningitis in a case of otosclerosis operated upon bilaterally. Arch Otolaryngol 1972;96:130-7.
11. Benitez JT. Stapedectomy and fatal meningitis. A human temporal bone study. ORL Otorhinolaryngol Relat Spec 1977;39:94-100.
12. Arnold W, Bredberg G, Gstottner W, et al. Meningitis following cochlear implantation: pathomechanisms, clinical symptoms, conservative and surgical treatments. ORL J Otorhinolaryngol Relat Spec 2002;64:382-9.
13. Fayad J, Linthicum FH Jr, Otto SR, et al. Cochlear implants: histopathologic findings related to performance in 16 human temporal bones. Ann Otol Rhinol Laryngol 1991;100:807-11.
14. Linthicum FH Jr, Fayad J, Otto SR, et al. Cochlear implant histopathology. Am J Otol 1991;12:245-311.
15. O'Leary MJ, Fayad J, House WF, et al. Electrode insertion trauma in cochlear implantation. Ann Otol Rhinol Laryngol 1991;100:695-9.
16. Zappia JJ, Niparko JK, Oviatt DL, et al. Evaluation of the temporal bones of a multichannel cochlear implant patient. Ann Otol Rhinol Laryngol 1991;100:914-21.
17. Marsh MA, Jenkins HA, Coker NJ. Histopathology of the temporal bone following multichannel cochlear implantation. Arch Otolaryngol Head Neck Surg 1992;118:1257-65.
18. Shepherd RK, Matsushima J, Martin RL, et al. Cochlear pathology following chronic electrical stimulation of the auditory nerve: II. Deafened kittens. Hear Res 1994;81:150-66.
19. Clark GM, Shute SA, Shepherd RK, et al. Cochlear implantation: osteoneogenesis, electrode-tissue impedance, and residual hearing. Ann Otol Rhinol Laryngol Suppl 1995;166:40-2.
20. Nakai Y, Sakashita T, Kubo T, et al. Temporal bone pathology of a patient with cochlear implant. ORL J Otorhinolaryngol Relat Spec 1997;59:230-4.
21. Nadol JB Jr, Shiao JY, Burgess BJ, et al. Histopathology of cochlear implants in humans. Ann Otol Rhinol Laryngol 2001;110:883-91.
22. Dahm MC, Clark GM, Franz BK, et al. Cochlear implantation in children: labyrinthitis following pneumococcal otitis media in unimplanted and implanted cat cochleas. Acta Otolaryngol 1994;114:620-5.
23. Nadol JB Jr, Ketten DR, Burgess BJ. Otopathology in a case of multichannel cochlear implantation. Laryngoscope 1994;104:299-303.
24. Fan-Havard P, Nahata MC. Treatment and prevention of infections of cerebrospinal fluid shunts. Clin Pharmacol 1987;6:866-80.
25. Braimbridge MV, Eykyn SJ. Prosthetic valve endocarditis. J Antimicrob Chemother 1987;20(suppl A):173-80.
26. Sherertz RJ, Carruth WA, Marosok RD, et al. Contribution of vascular catheter material to the pathogenesis of infection: the enhanced risk of silicone in vivo. J Biomed Mater Res 1995;29:635-45.
27. Ronan A, Gogg GG, Klug GL. Cerebrospinal fluid shunt infections in children. Pediatr Infect Dis J 1995;14:782-6.
28. Stickler DJ, Evans A, Morris N, et al. Strategies for the control of catheter encrustation. Int J Antimicrob Agents 2002;19:499-506.
29. Chuard C, Lucet JC, Rohner P, et al. Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials. J Infect Dis 1991;163:1369-73.
30. Williams I, Venables WA, Lloyd D, et al. The effects of adherence to silicone surfaces on antibiotic susceptibility in Staphylococcus aureus. Microbiology 1997;143:2407-13.
31. Katzin WE, Feng LJ, Abbuhl M, et al. Phenotype of lymphocytes associated with the inflammatory reaction to silicone gel breast implants. Clin Diagn Lab Immunol 1996;3:156-61.
32. Rice JM, Fisher AC, Hunt JA. Macrophage-polymer interactions. J Biomater Sci Polym Ed 1998;9:833-47.
33. Iribarren P, Correa SG, Sodero N, et al. Activation of macrophages by silicones: phenotype and production of oxidant metabolites. BMC Immunol 2002;3:6.
34. Mena EA, Kossovsky N, Chu C, et al. Inflammatory intermediates produced by tissues encasing silicone breast prostheses. J Invest Surg 1995;8:31-42.
35. Boelens JJ, van der Poll T, Zaat SA, et al. Interleukin-1 receptor type I gene-deficient mice are less susceptible to Staphylococcus epidermidis biomaterial-associated infection than are wild-type mice. Infect Immunol 2000;68:6924-31.
36. Kao WJ, Liu Y, Gundloori R, et al. Engineering endogenous inflammatory cells as delivery vehicles. J Control Release 2002;78:219-33.
37. Borges LF. Cerebrospinal fluid shunts interfere with host defenses. Neurosurgery 1982;10:55-60.
38. Zimmerli W, Waldvogel FA, Vaudaux P, et al. Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis 1982;146:487-97.
39. Zimmerli W, Lew PD, Waldvogel FA. Pathogenesis of foreign body infection. Evidence of a local granulocyte defect. J Clin Invest 1984;73:1191-200.
40. Kaplan SS, Basford RE, Kormos RL, et al. Biomaterial associated impairment of local neutrophil function. ASAIO Trans 1990;36:M172-5.
41. Kaplan SS, Basford RE, Jeong MH, et al. Mechanisms of biomaterial-induced superoxide release by neutrophils. J Biomed Mater Res 1994;28:377-86.
42. Fabre T, Belloc F, Dupuy B, et al. Polymorphonuclear cell apoptosis in exudates generated by polymers. J Biomed Mater Res 1999;44:429-35.
43. Beam TR Jr. Sequestration of staphylococci at an inaccessible focus. Lancet 1979;2:227-8.
44. Gresham HD, Lowrance JH, Caver TE, et al. Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol 2000;164:3713-22.
45. Boelens JJ, Dankert J, Murk JL, et al. Biomaterial-associated persistence of Staphylococcus epidermidis in pericatheter macrophages. J Infect Dis 2000;181:1337-49.
46. Bayston R, Lambert E. Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. J Neurosurg 1997;87:247-51.
47. Grapski JA, Cooper SL. Synthesis and characterization of non-leaching biocidal polyurethanes. Biomaterials 2001;22:2239-46.
48. Davenas J, Thevenard P, Philippe F, et al. Surface implantation treatments to prevent infection complications in short term devices. Biomol Eng 2002;19:263-8.
49. Tshefu K, Zimmerli W, Waldvogel FA. Short-term administration of rifampin in the prevention or eradication of infection due to foreign bodies. Rev Infect Dis 1983;Suppl 3:S474-80.
50. Borges LF. Host Defenses. Neurol Clin North Am 1992;3:275-8.
51. Bluestone CD. Prevention of meningitis. Cochlear implants and inner ear abnormalities. Arch Otolaryngol Head Neck Surg 2003;129:279-81.